OPTIMIZING REPERFUSION OUTCOMES IN ACUTE ISCHEMIC STROKE: A MULTIMODAL STATISTICAL ANALYSIS OF PATIENT ELIGIBILITY AND CLINICAL TRAJECTORY
Abstract
Acute ischemic stroke (AIS) remains a leading cause of global mortality and long-term disability, with approximately 87% of all stroke cases being ischemic in nature. The fundamental goal of acute management is the rapid restoration of blood flow to salvage the ischemic penumbra—a critically hypo-perfused area that is potentially salvageable but progresses toward irreversible infarction at a rate of approximately 1.9 million neurons per minute. However, the restoration of blood flow is a double-edged sword; while necessary, it can trigger an "ischemic cascade" involving glutamate-mediated excitotoxicity, calcium-mediated cell death, and the generation of reactive oxygen species (ROS), leading to ischemia-reperfusion injury (IRI). Given that the number needed to treat (NNT) to prevent one death or disability is 7 when treated within three hours, precise patient selection is paramount to maximizing therapeutic efficacy while minimizing complications like symptomatic intracranial hemorrhage (sICH).